Exane Derivatives’s Vontier VNT Stock Holding History

Exane Derivatives’s Portfolio VNT Stock Details VNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-102	Closed	-$2.59K	–	990
2022 Q1	$2.59K	Buy	+102	New	+$2.7K	﹤0.01%	735
2021 Q4	–	Sell	-102	Closed	-$3.43K	–	1041
2021 Q3	$3.43K	Hold	102	–	–	﹤0.01%	760
2021 Q2	$3.23K	Hold	102	–	–	﹤0.01%	795
2021 Q1	$3.09K	Hold	102	–	–	﹤0.01%	647
2020 Q4	$3.41K	Buy	+102	New	+$3.15K	﹤0.01%	583

Other funds holding VNT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Exane Derivatives's VNT Position: Q2 2022 in Review

Exane Derivatives sold out of Vontier (VNT) in Q2 2022, closing a stake of 102 shares — an estimated $2.59K sold.

Exane Derivatives first reported a position in VNT in Q4 2020 and held it in 5 quarters. The position peaked at $3.43K in Q3 2021. 441 funds tracked by Wall St. Rank hold VNT as of Q2 2022.

Exane Derivatives reported no remaining Vontier position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 102 Vontier shares in Q2 2022, an estimated $2.59K.
Exane Derivatives first reported a position in Vontier in Q4 2020 and held it in 5 quarters.
Exane Derivatives's Vontier position peaked at $3.43K in Q3 2021.
441 funds tracked by Wall St. Rank held Vontier as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.